Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2025

Conditions
Healthy VolunteersFemaleProgesteronePremenopausal
Interventions
DRUG

Micronized progesterone (oral capsules)

Two doses of 400 mg total micronized progesterone, administered as 2 × 200 mg capsules \~34 hours and \~10 hours prior to infusion trial, taken with a standardized nutritional drink.

DRUG

placebo capsule

Matched oral placebo capsules administered on the same schedule (\~34 and \~10 hours prior to infusion trial) with a standardized nutritional drink.

Trial Locations (1)

L8S 4K1

Exercise Metabolism Research Laboratory, Hamilton

All Listed Sponsors
lead

McMaster University

OTHER